William Valle

Chief Executive Officer & Director at NxStage Medical, Inc.

William Valle

William Valle

Chief Executive Officer & Director at NxStage Medical, Inc.

Overview
Career Highlights

NxStage Medical, Inc.
Fresenius Medical Care Holdings, Inc.
Fresenius Securities, Inc.

RelSci Relationships

859

Number of Boards

4

Birthday

1961

Age

58

Contact Data
Trying to get in touch with William Valle? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals William Valle likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Executive Officer at Fresenius Medical Care AG & Co. KGaA

Relationship likelihood: Strong

Chief Financial Officer at Fresenius Medical Care AG & Co. KGaA

Relationship likelihood: Strong

Member of the Management Board & Chief Executive Officer, Asia-Pacific at Fresenius Medical Care AG & Co. KGaA

Relationship likelihood: Strong

Director at Fresenius Medical Care Holdings, Inc.

Relationship likelihood: Strong

Manager at Fresenius Medical Care Coral Gables LLC

Relationship likelihood: Strong

Head, EMEA at Fresenius Medical Care Holdings, Inc.

Relationship likelihood: Strong

CAO-Global Law, Compliance & Intellectual Property at Fresenius Medical Care Management AG

Relationship likelihood: Strong

Founder at NxStage Medical, Inc.

Relationship likelihood: Strong

Chief Executive Officer-Global Research & Development at Fresenius Medical Care Management AG

Relationship likelihood: Strong

Chief Executive Officer at MagForce AG

Relationship likelihood: Strong

Paths to William Valle
Potential Connections via
Relationship Science
You
William Valle
Chief Executive Officer & Director at NxStage Medical, Inc.
Career History
Chief Executive Officer & Director
2019 - Current

NxStage is more than just a company; we are leading the renal revolution. By our own design, we’re at the leading edge of a movement to transform renal care. To make it simpler. To make it portable. To expand treatment options for clinicians by overcoming traditional barriers. To enhance patient freedom and fulfillment. With significant breakthroughs already behind us - and others in the pipeline - NxStage is finding itself at the forefront of dramatically improved renal care, thanks to innovative yet simple therapeutic solutions that benefit patients, caregivers, and society. Our approach – and success – is inspiring patients and providers. We’re not working alone. Part of our success has come through working closely with customers, patients, industry partners, and government leaders and agencies to realize the vision of better, simpler, more accessible renal care. Our ultimate purpose is to improve the lives of renal patients, and our approach is already resulting in changed lives and industry improvements. Together, we’re changing traditional perceptions of how renal care can be delivered. NxStage innovations are expanding and improving treatment options – and giving patients and caregivers the ease and flexibility to perform treatment when they want, where they want, and how they want. We found the future of renal care because we looked for it. Thanks to forward-thinking care partners, patients, and NxStage inventors and engineers, a new era has arrived. This is great news for the estimated 2 million people around the world suffering from chronic kidney failure, or End-Stage Renal Disease (ESRD) including 571,414 in the U.S.1 It’s also good news for the hundreds of thousands of patients every year in the U.S. who suffer from acute kidney failure due to surgery, trauma, poisoning, or other emergent health situations.

Chief Executive Officer-North America
2017 - Current

Fresenius Medical Care AG & Co. KGaA engages in the provision of products and services for patients with chronic kidney failure. It also develop and manufacture a variety of health care products, which includes dialysis and non-dialysis products. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Chief Executive Officer
2017 - Current

Fresenius Medical Care Holdings, Inc. provides kidney dialysis services and renal care products. It offers specialty pharmacy and laboratory services as well as manufacturing and distributing dialysis equipment, disposable products, and renal pharmaceuticals. The company was founded in 1996 and is headquartered in Waltham, MA.

Boards & Committees
Chief Executive Officer & Director
2019 - Current

NxStage is more than just a company; we are leading the renal revolution. By our own design, we’re at the leading edge of a movement to transform renal care. To make it simpler. To make it portable. To expand treatment options for clinicians by overcoming traditional barriers. To enhance patient freedom and fulfillment. With significant breakthroughs already behind us - and others in the pipeline - NxStage is finding itself at the forefront of dramatically improved renal care, thanks to innovative yet simple therapeutic solutions that benefit patients, caregivers, and society. Our approach – and success – is inspiring patients and providers. We’re not working alone. Part of our success has come through working closely with customers, patients, industry partners, and government leaders and agencies to realize the vision of better, simpler, more accessible renal care. Our ultimate purpose is to improve the lives of renal patients, and our approach is already resulting in changed lives and industry improvements. Together, we’re changing traditional perceptions of how renal care can be delivered. NxStage innovations are expanding and improving treatment options – and giving patients and caregivers the ease and flexibility to perform treatment when they want, where they want, and how they want. We found the future of renal care because we looked for it. Thanks to forward-thinking care partners, patients, and NxStage inventors and engineers, a new era has arrived. This is great news for the estimated 2 million people around the world suffering from chronic kidney failure, or End-Stage Renal Disease (ESRD) including 571,414 in the U.S.1 It’s also good news for the hundreds of thousands of patients every year in the U.S. who suffer from acute kidney failure due to surgery, trauma, poisoning, or other emergent health situations.

Member, Management Board
Current

Fresenius Medical Care AG & Co. KGaA engages in the provision of products and services for patients with chronic kidney failure. It also develop and manufacture a variety of health care products, which includes dialysis and non-dialysis products. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.

Chief Executive Officer & Director
Current

Fresenius Securities, Inc. manufactures and distributes medical products. It provides treatment of kidney failure by hemodialysis and peritoneal dialysis machines. The firm also offers a computer interface module, which performs on-line data collection during dialysis. The company was founded on March 15, 198 and is headquartered in Walnut Creek, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by William Valle. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of William Valle's profile does not indicate a business or promotional relationship of any kind between RelSci and William Valle.